Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A diagnosis of breast cancer with evidence of 1) unresectable, locally recurrent, or 2) metastatic disease.
HER2 positive disease (3+ by immunohistochemistry \[IHC\] or FISH-positive)
Candidate for treatment with trastuzumab. Prior treatment with trastuzumab and or/ lapatinib in the neoadjuvant, adjuvant or metastatic disease setting is permitted. Treatment with hormone therapy in the adjuvant and/or advanced disease setting is permitted.
You may not be if
Prior treatment with \>1 regimen of cytotoxic therapy in the advanced disease setting. Adjuvant chemotherapy is permitted
Prior exposure to trastuzumab if the patient had developed severe hypersensitivity reactions.
